id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-309024-pu830bn9	Bernardo, Luca	Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature	2020-09-14		.txt	text/plain	2959	158	41	title: Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature In this article, we present the case of a Black patient with acute pneumonia who benefited greatly from tocilizumab, but developed severe prolonged neutropenia. Considering the increasing use of tocilizumab among patients with coronavirus disease 2019 (COVID-19), this case warrants further research regarding the possible adverse hematological effects that need to be monitored in order to prevent secondary infections. Coronavirus disease 2019 (COVID19) , an emergent pandemic infection caused by the novel β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targets the lungs but also affects the heart and kidneys [1] . In this article, we report the case of a patient with respiratory failure related to COVID-19 who had a rapid favorable outcome after two doses of tocilizumab, but developed severe prolonged neutropenia.	./cache/cord-309024-pu830bn9.txt	./txt/cord-309024-pu830bn9.txt